SMARCA4 and thoracic aortic aneurysm: Studies have found that the expression of Smarca4 in the aortic middle layer of patients with thoracic aortic aneurysm (TAA) is significantly increased, and in human aortic VSMCs cultured in vitro, overexpression of Smarca4 can promote apoptosis and inhibit proliferation of VSMCs [19].